CHICAGO, IL — Almost nine in 10 patients implanted with defibrillators who were also eligible for cardiac resynchronization therapy (CRT) actually did receive the pacing therapy in a US nationwide ...

London, UK - 1 Sept 2015: Most patients with a cardiac resynchronisation therapy (CRT) pacemaker would not benefit from the addition of a defibrillator, according to results from the CeRtiTuDe cohort ...

A large observational study published in JAMA suggests that patients with left bundle-branch block (LBBB) and longer QRS duration derive the most benefit from a cardiac resynchronization therapy ...

Dallas, TX - The largest-yet analysis of its kind supports the use of cardiac resynchronization therapy (CRT), either with or without defibrillator backup, in patients with NYHA class 4 heart failure, ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO, Fla. — Each year, from 2003 to 2011, mortality rates improved for patients with HF and reduced ejection ...

AMSTERDAM, the Netherlands—Among patients with heart failure with reduced ejection fraction (HFrEF), a previously implanted pacemaker or ICD, and a significant RV pacing burden, upgrading to a cardiac ...

Among patients with nonischemic cardiomyopathy who require cardiac resynchronization therapy, a pacemaker may have comparable efficacy and more cost efficiency compared with a defibrillator, according ...

Primary analysis of the MADIT-CRT trial demonstrated that male and female patients with NYHA functional class I or II, left ventricular ejection fraction (LVEF) ≤0.30, and QRS duration ≥130 ms are ...

Ordinarily, of course, losing excess weight is often a good thing. But researchers are warning that some heart failure patients with CRT-D implants (cardiac resynchronization therapy with ...

Study Supplements Earlier Data Showing Reduction in Hospital Readmissions for Heart Failure Patients with AdaptivCRT Technology MINNEAPOLIS, USA and NICE, FRANCE - New data from the Medtronic, Inc.

Medical devices major St. Jude Medical ( STJ) has won the European CE Mark approval for its MultiPoint Pacing Quadra Assura MP cardiac resynchronization therapy defibrillator (CRT-D). This ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved ...